WASHINGTON, Feb. 16 (UPI) -- U.S. Marshals, acting for the Food and Drug Administration, seized tainted dietary supplements from Globe All Wellness LLC in Hollywood, Fla., officials said.
Howard Sklamberg, director of the Office of Compliance in the FDA's Center for Drug Evaluation and Research, said several of the seized products contain
sibutramine hydrochloride, the active ingredient in the obesity drug Meridia.
Meridia was withdrawn from the U.S. market in December 2010 after clinical data demonstrated the drug increased the risk of heart attack and stroke.
Globe All marketed its products with claims that its products could lower blood pressure and cholesterol, among others. Under the Federal Food, Drug and Cosmetic Act, products offered for such use are considered to be drugs, since they are intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease, Sklamberg said.
The company's products are drugs that have not been approved by the FDA for their claimed uses, the FDA said.
"Companies that distribute products containing undisclosed drugs are not only breaking the law, they are putting consumers at risk," Sklamberg said in a statement. "With these kinds of hidden dangers, consumers cannot make informed decisions about the products they are taking."
The FDA seized various lots of the following products:
-- SlimXtreme Gold
No illnesses were associated to date with Globe All's products. Illnesses or serious side effects related to the use of these products should be reported to the FDA via MedWatch's online form or by calling 1-800-FDA-1088.
|Additional Health News Stories|
MAYS LANDING, N.J., May 18 (UPI) --A New Jersey woman was charged with murder Friday after police found her husband's body in a closet six years after he supposedly ran off with a girlfriend.
WASHINGTON, May 17 (UPI) --James Taylor will headline a concert at the White House next week, when the Library of Congress honors Carole King with the Gershwin Prize for Popular Song.
CHICAGO, May 18 (UPI) --Consulting firm Accenture said it would buy Chicago start-up marketing firm Acquity Group for $316 million or $13 per share, more than double its share value.